Table 3. Mean and standard deviation of anti-atherogenic variables at baseline before and after 8-weeks, with (HSG) and without (CG) training.
|
|
HSG (n = 11) |
CG (n = 10) |
| HDL-c (mmol/L) |
Pre |
0.8 ± 0.1 † |
1.7 ± 0.1 |
| Post |
0.9 ± 0.1 |
0.9 ± 0.1 * |
| TAG (mmol/L) |
Pre |
1.1 ± 0.2 † |
1.4 ± 0.2 |
| Post |
1.1 ± 0.1 |
1.3 ± 0.2 |
| Non HDL (mmol/L) |
Pre |
3.5 ± 0.7 |
2.8 ± 0.6 |
| Post |
3.7 ± 1.3 |
2.9 ± 0.7 |
| BDNF (ng·mL-1) |
Pre |
108.8 ± 56.7 |
66.1 ± 40.2 |
| Post |
92.6 ± 15.9 |
67.1 ± 43.9 |
Mean ± standard deviation. HDL-c = high density lipoprotein; TAG= triacylglycerol; Non HDL= non high density lipoprotein; BDNF= brain derived neurotropic factor; mmol/L = millimole per liter; ng·mL-
1 = nanograms per milliliter; HSG = high intensity aerobic exercise combined strength group; CG = control group;* = significant difference compared with the pre-training moment (p < 0.05);† = significant difference compared with the control group (p < 0.05).
